Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Melanoma 14Squamous Cell Carcinoma of Head and Neck 12Colorectal Neoplasms 11Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 10Carcinoma, Renal Cell 7Prostatic Neoplasms 6Head and Neck Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Neoplasms 5Lung Neoplasms 5Biliary Tract Neoplasms 5Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Hepatocellular 3Advanced Solid Tumors 3Stomach Neoplasms 2Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Liver Neoplasms 2Kidney Neoplasms 2Gallbladder Neoplasms 2Esophageal Squamous Cell Carcinoma 2

Interventions

Gemcitabine 34Cisplatin 21Capecitabine 18Oxaliplatin 15Leucovorin 10Fluorouracil 10Irinotecan 8Erlotinib Hydrochloride 7pembrolizumab 5Bevacizumab 5Radiotherapy 4Carboplatin 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Watchful Waiting 3Taxes 3Sorafenib 3Platinum 3Interleukin-12 Subunit p35 3Immunohistochemistry 3Docetaxel 31,2-diaminocyclohexaneplatinum II citrate 3trifluridine tipiracil drug combination 2tremelimumab 2regorafenib 2durvalumab 2dehydroftorafur 2Trastuzumab 2Paclitaxel 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Gallbladder Neoplasms × tremelimumab × Clear all
NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
40 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT03473574 2023-06-15

IMMUCHEC

AIO-Studien-gGmbH

Phase 2 Completed
128 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡